NDRG1 overexpression enhances aerobic glycolysis and imparts growth advantages to cells, induces the expression of hypoxia-associated genes, and causes lipid metabolism dysfunction in breast cancer (Sevinsky et al., 2018). This evidence concerns the gene NDRG1 and breast carcinoma.